🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 for elderly patients — September 2026 Page 2

Oral GLP-1 for elderly patients — September 2026

hans_munich Wed, Jan 28, 2026 at 7:29 AM 7 replies 906 viewsPage 2 of 2
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jan 28, 2026 at 8:43 AM#6
labquiet_amy said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

Last edited: Jan 28, 2026 at 12:43 PM
14 9steve_okc, dave_SLC, FDA_TrackerJim and 11 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jan 28, 2026 at 9:11 AM#7

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

13 8tyler_CSCS, VanRx_Mike, steve_okc and 10 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Jan 28, 2026 at 9:39 AM#8
PeptideChemSF said:
I do not accept that the fasting window is a minor inconvenience.

Adding the part of the answer the thread has not reached. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

12 7MikeFit_NJ, InsuranceTom, WendyG_ATL and 9 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Jan 28, 2026 at 10:07 AM#9

Following on from jason_paloalto — and this may be the naive question:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

Last edited: Jan 28, 2026 at 12:07 PM
11 6NurseKim_ATL, paul_denver, TinaHashiRN and 8 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Jan 28, 2026 at 12:20 PM#10

Closing the loop on my own question.

I moved the tablet to the moment I wake up rather than trying to fit it around breakfast, and the difference in the following weeks was obvious. It was a timing problem, not a dose problem.

15 15emma_london, tammy_FL, Dr.LipidDallas and 12 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register